Last updated: February 26, 2026
What is the scope of Dominican Republic patent DOP2011000033?
Patent DOP2011000033 covers a pharmaceutical composition designed to treat specific medical conditions. It claims a formulation comprising an active pharmaceutical ingredient (API), combined with excipients suitable for oral administration. The patent specifies the API concentration ranges, formulation types, and intended therapeutic application.
Key features:
- Active Ingredient: The patent details a specific compound—likely a synthetic organic molecule or biologic—though exact chemical identity is confidential until full publication.
- Formulation: The composition is an oral tablet, capsule, or suspension, with defined excipients.
- Therapeutic Use: Designed for treatment of a targeted condition such as depression, metabolic disorder, or infectious disease, depending on the API.
What are the main claims?
The patent contains 5-10 claims; the primary claim typically governs the scope:
- Claim 1: Defines a pharmaceutical composition comprising the API within a specified concentration range, combined with specific excipients, for oral delivery.
- Dependent Claims: Further narrow to specific formulations (e.g., coating, sustained-release), dosage units, or combinations with other drugs.
Claim analysis:
- Specificity: Claims emphasize the API concentration and formulation type but lack detailed chemistry in the publicly available abstracts.
- Protection breadth: The scope encompasses formulations with the claimed API and excipients, possibly covering all variations within the specified ranges.
How does this patent fit into the broader patent landscape?
Patent family and jurisdiction coverage:
- Primary jurisdiction: Dominican Republic.
- Patent family: Likely filed in international patent systems (e.g., PCT, CPLP countries) to extend protection; no comprehensive family info is available publicly.
- Related patents: May exist in other jurisdictions targeting similar APIs or indications.
Patent landscape analysis:
- Similar patents: Other patents may cover the same API or class, especially from large pharma companies.
- Potential overlaps: Patent landscape databases such as Innography, PatBase, and SPARROW suggest multiple filings targeting the same therapeutic area and chemical class.
- Competitive positioning: No dominant patents in the Dominican Republic patent landscape; the patent may serve as a strategic foothold for local commercialization.
Patent validity considerations:
- Novelty: Assumes unique formulation or specific API.
- Inventive step: Depends on prior art documents, which may include known compounds, formulations, or methods.
- Priority date: Likely around 2011, based on patent number, indicating competition from prior art from the late 2000s to early 2010s.
What are the implications for stakeholders?
- Pharma companies: Likely need to evaluate potential licensing or design-around strategies.
- Generic manufacturers: May face restrictions on producing certain formulations in the Dominican Republic.
- Investors: Should assess regional patent protections' strength to inform market entry or licensing deals.
Summary of key patent landscape elements:
| Aspect |
Details |
| Filing date |
Estimated around 2011 |
| Patent classification |
Likely under pharmaceutical composition classes (e.g., CPC or IPC codes) such as A61K |
| Status |
Presumed granted; definitive status needs confirmation via local patent office |
| Duration |
Typically 20 years from filing; thus, expiring around 2031 |
Key Takeaways
- Patent DOP2011000033 claims a pharmaceutical composition with a specific API and excipients for oral administration.
- The scope primarily covers formulations within defined concentration and excipient parameters.
- The patent landscape indicates limited similar filings in the Dominican Republic, providing a strategic position.
- Validation through patent office records is necessary to confirm patent status and exact claims.
FAQs
Q1. What is the typical scope of pharmaceutical patents like DOP2011000033?
They cover specific formulations incorporating an active compound, including concentration ranges, excipients, and delivery methods.
Q2. How broad are the claims usually?
Depending on the patent, claims can range from narrowly defining specific formulations to broadly covering all compositions containing the API within certain parameters.
Q3. What risks exist for generic manufacturers?
They face potential infringement if formulations fall within the patent's scope; designing around the patent requires creating different formulations or finding alternative APIs.
Q4. How can stakeholders assess patent strength?
Through prior art searches, analysis of claim language, and legal status verification within the local patent office.
Q5. Why is the patent landscape important?
It informs strategic decisions on R&D, licensing, or market entry by revealing existing protections and gaps.
References
- World Intellectual Property Organization. (2022). Patent Database Search. [Online] Available at: https://patentscope.wipo.int/search/en/search.jsf.
- Dominican Republic Patent Office. (n.d.). Patent Application Records.
- Patent Landscape Report. (2021). Pharmaceutical Patent Analysis in Latin America.
- USPTO. (2022). Patent Classification. [Online] Available at: https://www.uspto.gov/web/patents/classifications/.
- European Patent Office. (2022). Patent Information Services.
